Findings shed new light on dry eyes in postmenopausal women

Article

Results of a study demonstrated the efficacy of a droppable gel artificial tear product for improving signs and symptoms of dry eye disease in post-menopausal women and suggested it may be a particularly appropriate option for patients with non-meibomian gland-related, aqueous-deficient dry eye.

Boston-Results of a prospective, randomized, double-masked, controlled study demonstrated the efficacy of a droppable gel artificial tear product (Systane Ultra Lubricant Eye Drops, Alcon) for improving signs and symptoms of dry eye disease in postmenopausal women and suggested it may be a particularly appropriate option for patients with non-meibomian gland-related, aqueous-deficient dry eye, co-investigator Jillian F. Meadows, MS, reported at the annual meeting of the American Academy of Optometry.

Study subjects were randomized to receive either an artificial tear gel drop containing propylene glycol and polyethylene glycol or a control with no demulcents (soft contact lens rewetting drop; Sensitive Eyes Eye Drops, Bausch + Lomb). The patients were instructed to instill 1 to 2 drops in each eye Q.I.D. Follow-up visits were conducted after 2 and 4 weeks for assessment of changes in corneal staining and symptoms using the Ocular Surface Disease Index (OSDI).

To be eligible for inclusion in the study, women had to have a baseline sum corneal staining score of at least 3 in one eye and at least one of the following signs or symptoms: OSDI >12; Schirmer score ≤10 mm/5 minutes; tear breakup time (TBUT) <6 seconds; history of use of artificial tears; or a previous diagnosis of dry eye. Patients with Sjögren's syndrome, active infection or inflammation not associated with dry eye, or ocular allergy were excluded.

Thirty-nine women, 22 using the gel drop and 17 in the control group, completed the study. Outcomes analyses were performed for the entire study population and for two subgroups: women with aqueous deficiency, defined as Schirmer's ≤10 mm/5 minutes (22 patients); and women without meibomian gland dysfunction (MGD) based on having normal meibomian gland secretions (grade 0 or 1, 24 patients). The average age of women in the study was 62, and they were predominantly white.

Both groups showed improvement. While women who used the gel drop showed a numerically greater score than the control-2.13 versus 1.59-the difference was not statistically significant. However, subgroup analyses revealed statistically significant differences favoring the artificial tear gel drop in both subgroups at follow-up. The change in corneal staining score with the gel drop was especially notable for the women with aqueous-deficient dry eye, Meadows said.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.